Cargando…
New developments and future opportunities in biomarkers for amyotrophic lateral sclerosis
Modern technology has improved the ability to probe effectively the underlying biology of ALS by examination of genomic, proteomic and physiological changes in patients with ALS, as well as to monitor functional and structural changes during the course of disease. While effective treatments for ALS...
Autores principales: | Chen, Xueping, Shang, Hui-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589120/ https://www.ncbi.nlm.nih.gov/pubmed/26425343 http://dx.doi.org/10.1186/s40035-015-0040-2 |
Ejemplares similares
-
Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis
por: Chen, Xueping, et al.
Publicado: (2016) -
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
por: Rogers, Mary-Louise, et al.
Publicado: (2023) -
MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis
por: Ricci, Claudia, et al.
Publicado: (2018) -
Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis
por: Katzeff, Jared S., et al.
Publicado: (2022) -
Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis
por: Klingl, Yvonne E., et al.
Publicado: (2020)